These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 190881)

  • 21. The renin-angiotensin system and its blockers.
    Igić R; Škrbić R
    Srp Arh Celok Lek; 2014; 142(11-12):756-63. PubMed ID: 25731011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism of vasoactive peptides by human endothelial cells in culture. Angiotensin I converting enzyme (kininase II) and angiotensinase.
    Johnson AR; Erdös EG
    J Clin Invest; 1977 Apr; 59(4):684-95. PubMed ID: 191471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular biology of the vascular renin-angiotensin system.
    Samani NJ; Swales JD
    Blood Vessels; 1991; 28(1-3):210-6. PubMed ID: 1848124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in responses to bradykinin, angiotensin I, and angiotensin II during the induction phase of one-kidney, one-wrapped hypertension and associated arterial disease in rabbits.
    Campbell WG; Donohue JA; Duket LH
    Am J Pathol; 1980 Feb; 98(2):457-84. PubMed ID: 6243872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide.
    VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP
    Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
    Williams GH; Hollenberg NK
    N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biochemistry of the renin-angiotensin system and its role in hypertension.
    Skeggs LT; Dorer FE; Kahn JR; Lentz KE; Levine M
    Am J Med; 1976 May; 60(6):737-48. PubMed ID: 190880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of vascular angiotensin converting enzyme in hypertension.
    Miyazaki M; Okamura T; Toda N
    J Hypertens Suppl; 1988 Dec; 6(3):S13-5. PubMed ID: 2852233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of angiotensin III by angiotensin-converting enzyme.
    Chiu AT; Ryan JW; Stewart JM; Dorer FE
    Biochem J; 1976 Apr; 155(1):189-92. PubMed ID: 180981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of angiotensin-converting enzyme-2 in the kidney.
    Burns KD
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):116-21. PubMed ID: 17293686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation.
    Swartz SL; Williams GH; Hollenberg NK; Moore TJ; Dluhy RG
    Hypertension; 1979; 1(2):106-11. PubMed ID: 233366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of converting enzyme in the responses of rabbit atria, aortas, and adrenal zona glomerulosa to [des-Asp1]angiotensin I.
    Ackerly JA; Tsai BS; Peach MJ
    Circ Res; 1977 Aug; 41(2):231-8. PubMed ID: 194729
    [No Abstract]   [Full Text] [Related]  

  • 33. The renin-angiotensin system and thirst: a reevaluation.
    Stricker EM; Bradshaw WG; McDonald RH
    Science; 1976 Dec; 194(4270):1169-71. PubMed ID: 186869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice?
    Lees KR; MacFadyen RJ; Reid JL
    Am J Hypertens; 1990 Nov; 3(11):266S-272S. PubMed ID: 2175623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitors.
    Kaplan HR; Cohen DM; Essenburg AD; Major TC; Mertz TE; Ryan MJ
    Fed Proc; 1984 Apr; 43(5):1326-9. PubMed ID: 6323223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE).
    Xiao HD; Fuchs S; Frenzel K; Teng L; Bernstein KE
    Crit Rev Eukaryot Gene Expr; 2004; 14(1-2):137-45. PubMed ID: 15104531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules.
    Li N; Zimpelmann J; Cheng K; Wilkins JA; Burns KD
    Am J Physiol Renal Physiol; 2005 Feb; 288(2):F353-62. PubMed ID: 15467007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of angiotensin I in isolated perfused guinea-pig and rat lung.
    Meyer DK; Liebig R; Abele M; Jobke A; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(2):183-7. PubMed ID: 181682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison between saralsin and converting enzyme inhibitor in hypertensive disease.
    Case DB; Wallace JM; Laragh JH
    Kidney Int Suppl; 1979 Mar; (9):S107-114. PubMed ID: 225598
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of pathophysiologic state on the metabolism of vasoactive peptides by mammalian lung.
    Stalcup SA; Leuenberger P; Greenbaum LM; Mellins RB; Turino GM
    Bull Eur Physiopathol Respir; 1979; 15(5):1031-44. PubMed ID: 228783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.